mvvp banner red border
Home The Team Portfolio Limited Partners Co-Investors News Articles Contact Us

MVVP logo

 

 


Satiogen

A San Diego-based startup biotech company founded by Andrew Young, M.D., Ph.D. developing novel therapeutic treatments for diabetes and obesity. A proof of concept human clinical trial was completed successfully in 2009. The Series A financing was led by Mesa Verde Venture Partners.       


LineaGen
www.lineagen.com

A Utah-based biomarker discovery company focusing on novel, patentable diagnostic testing tools and processes with a focus on the commercialization of diagnostics for Autism and Multiple Sclerosis. A $5.8 million Series A round was led by Sanderling Ventures and vSpring Capital.      


Elevation Pharmaceuticals
www.elevationpharma.com

A San Diego-based specialty pharmaceutical company aimed at reformulation of an existing COPD drugs, delivered in a nebulized format. Mesa Verde lead a convertible note financing at a discount into the Series A round of $30 million led by Canaan Partners. In September 2012, Elevation was acquired for up to $430 million by Sunovian.       


Medpacs
www.medipacs.com

A Tucson, Arizona and San Diego-based company developing advanced and innovative infusion pump technology for fluid delivery systems based upon electro-activated polymers. Mesa Verde participated in the Series A financing.       


Biomatrica
www.biomatrica.com

A San Diego-based company that develops and offers innovative technologies that stabilize biological materials at room temperature. Mesa Verde participated in the Series C financing as the company's first institutional investor.      


Exagen
www.exagen.com

An Albuquerque and San Diego-based discovery driven, patient focused CLIA registered molecular diagnostics laboratory.  Exagen has a growing menu of proprietary, largely internally developed genomic tests to enable more accurate diagnosis of Lupus and Rheumatoid Arthritis. Mesa Verde participated in the Series A and B financing.